Palatin Technologies, Inc. (PTN) financial statements (2021 and earlier)

Company profile

Business Address 4B CEDAR BROOK DRIVE
CRANBURY, NJ 08512
State of Incorp. NJ
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9144384082712
Cash and cash equivalents9144384082712
Receivables060 15   
Prepaid expense100000 
Other undisclosed current assets0001320
Total current assets:921043957112912
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Other noncurrent assets0000000
Total noncurrent assets:1010000
TOTAL ASSETS:931053957112913
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13412872
Accounts payable0122112
Accrued liabilities13211860
Debt 068600
Other liabilities000    
Other undisclosed current liabilities   35  1
Total current liabilities:1411551473
Noncurrent Liabilities
Long-term debt and lease obligation  061410 
Long-term debt, excluding current maturities  061410 
Capital lease obligations   00 
Liabilities, other than long-term debt0 0100 
Other liabilities0 0100 
Other undisclosed noncurrent liabilities  1    
Total noncurrent liabilities:0 171510 
Total liabilities:14126229173
Stockholders' equity
Stockholders' equity attributable to parent9110127(5)(18)1210
Preferred stock0000000
Common stock2222110
Additional paid in capital395394357350325303283
Accumulated other comprehensive loss   (0)(0)  
Accumulated deficit(306)(296)(332)(357)(343)(292)(274)
Total stockholders' equity:9110127(5)(18)1210
TOTAL LIABILITIES AND EQUITY:931053957112913

Income statement (P&L) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenue, net 45 13 
Gross profit:60606745 13 
Operating expenses(24)(25)(41)(55)(49)(30)(16)
Operating income (loss):363626(11)(49)(17)(16)
Nonoperating income (expense)1000(2)(1)0
Investment income, nonoperating1000000
Other nonoperating expense     (0) 
Interest and debt expense(0)(0)(1)(2)(3)(1)(0)
Income (loss) from continuing operations before equity method investments, income taxes:373525(13)(54)(19)(16)
Other undisclosed loss from continuing operations before income taxes(0)      
Income (loss) from continuing operations before income taxes:363525(13)(54)(19)(16)
Income tax expense (benefit)  (0)(1) 12
Net income (loss):363525(13)(54)(18)(14)
Other undisclosed net income attributable to parent00  310
Net income (loss) available to common stockholders, diluted:373625(13)(52)(18)(14)

Comprehensive Income ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net income (loss):363525(13)(54)(18)(14)
Comprehensive income (loss):363525(13)(54)(18)(14)
Other undisclosed comprehensive income, net of tax, attributable to parent00003  
Comprehensive income (loss), net of tax, attributable to parent:373625(13)(52)(18)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: